![]() |
Volumn 30, Issue 11, 2007, Pages
|
Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLIBENCLAMIDE;
INSULIN;
PANCREAS ISLET CELL ANTIBODY;
SULFONYLUREA;
ADULT;
CASE REPORT;
COGNITION;
DIABETES MELLITUS;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SUBSTITUTION;
ELECTROENCEPHALOGRAM;
GENE MUTATION;
GLUCOSE BLOOD LEVEL;
HISTORY OF MEDICINE;
HUMAN;
INSULIN TREATMENT;
INTELLIGENCE QUOTIENT;
LEARNING;
LEARNING DISORDER;
LETTER;
LONG TERM MEMORY;
MALE;
METABOLIC REGULATION;
NEUROLOGIC DISEASE;
NEUROPSYCHOLOGICAL TEST;
QUALITY OF LIFE;
STATISTICAL SIGNIFICANCE;
VERBAL BEHAVIOR;
ADULT;
AGE OF ONSET;
AMINO ACID SUBSTITUTION;
DIABETES MELLITUS;
HETEROZYGOTE DETECTION;
HUMANS;
INFANT;
MALE;
POTASSIUM CHANNELS, INWARDLY RECTIFYING;
SULFONYLUREA COMPOUNDS;
|
EID: 36049015306
PISSN: 01495992
EISSN: 01495992
Source Type: Journal
DOI: 10.2337/dc07-1196 Document Type: Letter |
Times cited : (27)
|
References (3)
|